Odyssey Health, Inc. Research and Development in Process
Odyssey Health, Inc. (ODYY) reported Research and Development in Process of $170.00 thousand for the 3-month period ending 2023-01-31, per its 10-Q filed 2023-03-17.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentInProcess · last filed 2023-03-17
- Odyssey Health, Inc. research and development in process for the quarter ending 2023-01-31 was $170.00K.
- Odyssey Health, Inc. research and development in process for the quarter ending 2022-07-31 was $0.00.
- Odyssey Health, Inc. research and development in process for the quarter ending 2022-04-30 was $0.00, a 100.00% decline year-over-year.
- Odyssey Health, Inc. research and development in process for the quarter ending 2022-01-31 was $0.00.
- Odyssey Health, Inc. research and development in process for fiscal 2022 was $0.00, a 100.00% decline from fiscal 2021.
- Odyssey Health, Inc. research and development in process for fiscal 2021 was $9.44M.
- Odyssey Health, Inc. research and development in process for fiscal 2020 was $0.00.
| Period end | Research and Development in Process 3 month | Research and Development in Process 6 month | Research and Development in Process 9 month | Research and Development in Process 12 month |
|---|---|---|---|---|
| 2023-01-31 | $170.00K 10-Q · filed 2023-03-17 | $170.00K 10-Q · filed 2023-03-17 | ||
| 2022-07-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-10-31 | $0.00 derived: sum of 2 quarters · filed 2022-10-31 | $0.00 derived: sum of 3 quarters · filed 2023-03-17 | $0.00 10-K · filed 2022-10-31 |
| 2022-04-30 | $0.00 10-Q · filed 2022-06-14 | $0.00 derived: sum of 2 quarters · filed 2023-03-17 | $0.00 10-Q · filed 2022-06-14 | |
| 2022-01-31 | $0.00 10-Q · filed 2023-03-17 | $0.00 10-Q · filed 2023-03-17 | ||
| 2021-07-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-10-31 | $9.44M derived: sum of 2 quarters · filed 2022-10-31 | $9.44M 10-K · filed 2022-10-31 | |
| 2021-04-30 | $9.44M 10-Q · filed 2022-06-14 | $9.44M 10-Q · filed 2022-06-14 | ||
| 2020-07-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-10-29 | $0.00 derived: sum of 2 quarters · filed 2021-10-29 | $0.00 10-K · filed 2021-10-29 | |
| 2020-04-30 | $0.00 10-Q · filed 2021-06-21 | $0.00 10-Q · filed 2021-06-21 |